Effects of Aerobic Versus Resistance Training on Bone Metabolism in Stage 3-4 Chronic Kidney Disease
NCT ID: NCT07133256
Last Updated: 2025-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2025-01-01
2025-07-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Aerobic Exercise Versus Resistance Exercise on Bone Density in Postmenopausal Diabetic Women
NCT06505044
The Effect of Aerobic Exercise on Bone Turnover Markers in Postmenopausal Patients
NCT06866561
Bone Response to Exercise in Women on Antiresorptive Medications
NCT04275011
Hormonal and Bone Turnover Marker Response to an Acute Bout of Resistance or Plyometric Exercise
NCT00572871
Bone and Body Composition Adaptations to Physical Training
NCT06972862
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study recruited 60 CKD patients (stage 3-4, aged 30-50 years) and randomly allocated them into two groups (n=30 each): a resistance training group and an aerobic exercise group. Both groups underwent supervised exercise 3 times per week for six months. Bone mineral density was assessed using dual-energy X-ray absorptiometry (DEXA) at the lumbar spine (L2-L4), femoral neck, and distal radius. Serum concentrations of OPG and RANKL were measured via ELISA at baseline and post-intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Resistance Exercise Group (Group A)
Participants in this arm engaged in supervised resistance training three times per week for six months. Each session included:
5-minute warm-up with dynamic stretching and range-of-motion exercises
30-minute resistance training using weight machines targeting major muscle groups (upper limbs, lower limbs, and trunk)
Intensity: 60% to 80% of one-repetition maximum (1-RM), adjusted progressively
10-minute cool-down with static stretching Sessions were monitored by trained physiotherapists.
Resistance Exercise
Structured machine-based resistance exercise protocol performed under supervision, targeting osteogenic loading to improve bone mineral density and alter bone metabolism markers in CKD stage 3-4 patients.
Aerobic Exercise Group (Group B)
Participants in this arm performed supervised aerobic exercise (treadmill walking) three times per week for six months. Each session included:
5-minute warm-up
30-minute treadmill walking at 60%-80% of age-predicted maximum heart rate (HRmax = 220 - age)
10-minute cool-down Exercise sessions were supervised by trained exercise professionals and tailored to maintain target heart rate zones.
Aerobic Training
Participants in this arm performed supervised aerobic exercise (treadmill walking) three times per week for six months. Each session included:
5-minute warm-up
30-minute treadmill walking at 60%-80% of age-predicted maximum heart rate (HRmax = 220 - age)
10-minute cool-down Exercise sessions were supervised by trained exercise professionals and tailored to maintain target heart rate zones.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resistance Exercise
Structured machine-based resistance exercise protocol performed under supervision, targeting osteogenic loading to improve bone mineral density and alter bone metabolism markers in CKD stage 3-4 patients.
Aerobic Training
Participants in this arm performed supervised aerobic exercise (treadmill walking) three times per week for six months. Each session included:
5-minute warm-up
30-minute treadmill walking at 60%-80% of age-predicted maximum heart rate (HRmax = 220 - age)
10-minute cool-down Exercise sessions were supervised by trained exercise professionals and tailored to maintain target heart rate zones.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with stage 3 or 4 chronic kidney disease (non-dialysis dependent)
* BMI between 20 and 24 kg/m²
* Not currently taking medications that affect bone density (e.g., corticosteroids, bisphosphonates)
* Non-smokers and abstinent from alcohol
* Not receiving hormone replacement therapy
* Willing and able to participate in supervised exercise sessions for 6 months
Exclusion Criteria
* Uncontrolled hypertension
* History of cardiovascular, musculoskeletal, endocrine, or metabolic bone disease
* Pregnant or planning pregnancy during the study period
* Participation in a structured exercise program within the last 3 months
* Contraindications to exercise as determined by medical evaluation
* Use of investigational drugs or enrollment in another clinical trial during the study period
30 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sinai University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amany Gomaa Atiaa
lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr. Shehab Abd E-Kader, Professor
Role: PRINCIPAL_INVESTIGATOR
1Department of Physical Therapy, Faculty of Medical Rehabilitation Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Manshyet El-Bakry Hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SU.REC.2025(45H)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.